These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38934142)

  • 1. Critically Ill Patients with COVID-19 Pneumonia Requiring Continuous Renal Replacement Therapy with oXiris® Membrane in a Third-Level Hospital in Northeast Mexico.
    Borbolla-Flores P; Villegas-Gutiérrez LY; Samaniego-Segovia BM; Torres-Quintanilla FJ; Gómez-Villarreal JP; Garza-Treviño RA; Rizo-Topete LM
    Blood Purif; 2024; 53(8):634-640. PubMed ID: 38934142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Clinical and Machine Data of Critically Ill Adult COVID Patients with Acute Kidney Injury Exposed to Enhanced Hemoadsorption during CRRT.
    Cama-Olivares A; Ortiz-Soriano V; Liu LJ; Carter S; Takeuchi T; Chen J; Tolwani AJ; Neyra JA
    Blood Purif; 2024; 53(6):476-485. PubMed ID: 38104535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracorporeal blood purification with Oxiris
    Abdelaty M; Mohamed A; Saad MO; Mitwally H; Alkadi MM; Hashim A; Al Malki H; Ali HS; Mohamed AS; Mustafa E; Alalawi A; Elshafei M; Othman M; Khatib M; Ibrahim AS
    Int J Artif Organs; 2023 Dec; 46(12):629-635. PubMed ID: 37926985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The haemodynamic effects of oXiris haemofilter in septic shock patients requiring renal support: A single-centre experience.
    Lumlertgul N; Srisawat N
    Int J Artif Organs; 2021 Jan; 44(1):17-24. PubMed ID: 32393096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial renal replacement therapy (RRT) modality associates with 90-day postdischarge RRT dependence in critically ill AKI survivors.
    Koyner JL; Mackey RH; Echeverri J; Rosenthal NA; Carabuena LA; Bronson-Lowe D; Harenski K; Neyra JA
    J Crit Care; 2024 Aug; 82():154764. PubMed ID: 38460295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous renal replacement therapy with the addition of CytoSorb cartridge in critically ill patients with COVID-19 plus acute kidney injury: A case-series.
    Alharthy A; Faqihi F; Memish ZA; Balhamar A; Nasim N; Shahzad A; Tamim H; Alqahtani SA; Brindley PG; Karakitsos D
    Artif Organs; 2021 May; 45(5):E101-E112. PubMed ID: 33190288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute Kidney Injury and Renal Replacement Therapy in Critically Ill COVID-19 Patients: Risk Factors and Outcomes: A Single-Center Experience in Brazil.
    Doher MP; Torres de Carvalho FR; Scherer PF; Matsui TN; Ammirati AL; Caldin da Silva B; Barbeiro BG; Carneiro FD; Corrêa TD; Ferraz LJR; Dos Santos BFC; Pereira VG; Batista MC; Monte JCM; Santos OFP; Bellomo R; Serpa Neto A; Durão MS
    Blood Purif; 2021; 50(4-5):520-530. PubMed ID: 33341806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between continuous renal replacement therapy and 28-day mortality of critically ill patients with COVID-19 receiving mechanical ventilation.
    Xu X; Liu K; Cheng P; Huang Y; Huang C; Wu W; Xing C; Mao H; Liu Y
    Clin Nephrol; 2021 Oct; 96(4):207-215. PubMed ID: 34236306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous renal replacement therapy in intensive care patients with COVID-19; survival and renal recovery.
    Eriksson KE; Campoccia-Jalde F; Rysz S; Rimes-Stigare C
    J Crit Care; 2021 Aug; 64():125-130. PubMed ID: 33878517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Provision of acute renal replacement therapy, using three separate modalities, in critically ill patients during the COVID-19 pandemic. An after action review from a UK tertiary critical care centre.
    Fisher R; Clarke J; Al-Arfi K; Saha R; Lioudaki E; Mehta R; Pahl C; Sharpe C; Bramham K; Hutchings S
    J Crit Care; 2021 Apr; 62():190-196. PubMed ID: 33422809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute Kidney Injury and COVID-19: A Picture from an Intensive Care Unit.
    Alessandri F; Pistolesi V; Manganelli C; Ruberto F; Ceccarelli G; Morabito S; Pugliese F;
    Blood Purif; 2021; 50(6):767-771. PubMed ID: 33412548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of early initiation of continuous renal replacement therapy based on the KDIGO classification on the prognosis of critically ill patients with acute kidney injury].
    Chen M; Hu B; Li Q; Liu J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Mar; 28(3):246-51. PubMed ID: 29917340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged Intermittent Renal Replacement Therapy for Acute Kidney Injury in COVID-19 Patients with Acute Respiratory Distress Syndrome.
    Ramirez-Sandoval JC; Gaytan-Arocha JE; Xolalpa-Chávez P; Mejia-Vilet JM; Arvizu-Hernandez M; Rivero-Sigarroa E; Torruco-Sotelo C; Correa-Rotter R; Vega-Vega O
    Blood Purif; 2021; 50(3):355-363. PubMed ID: 33105136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and outcome of critically ill COVID-19 patients with acute kidney injury: a single centre cohort study.
    Lowe R; Ferrari M; Nasim-Mohi M; Jackson A; Beecham R; Veighey K; Cusack R; Richardson D; Grocott M; Levett D; Dushianthan A;
    BMC Nephrol; 2021 Mar; 22(1):92. PubMed ID: 33722189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of CRRT with oXiris filter on hemodynamic instability in surgical septic shock with AKI: A pilot randomized controlled trial.
    Feng J; Zhang S; Ai T; Wang L; Gao Y; Li W; Zhu M
    Int J Artif Organs; 2022 Oct; 45(10):801-808. PubMed ID: 35864718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous Renal Replacement Therapy for a Patient with Severe COVID-19.
    Katagiri D; Ishikane M; Ogawa T; Kinoshita N; Katano H; Suzuki T; Fukaya T; Hinoshita F; Ohmagari N
    Blood Purif; 2021; 50(1):129-131. PubMed ID: 32526746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes among Patients Treated with Renal Replacement Therapy during Extracorporeal Membrane Oxygenation: A Single-Center Retrospective Study.
    Dado DN; Ainsworth CR; Thomas SB; Huang B; Piper LC; Sams VG; Batchinsky A; Morrow BD; Basel AP; Walter RJ; Mason PE; Chung KK
    Blood Purif; 2020; 49(3):341-347. PubMed ID: 31865351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COMPARISON OF OXIRIS AND CONVENTIONAL CONTINUOUS RENAL REPLACEMENT THERAPY IN MANAGING SEVERE ABDOMINAL INFECTIONS: IMPACT ON SEPTIC SHOCK MORTALITY.
    Liao XY; Chen YT; Liu MJ; Liao QX; Lin JD; Lin HR; Huang YH; Zhou Y
    Shock; 2024 Oct; 62(4):529-538. PubMed ID: 39158926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The absorbing filter Oxiris in severe coronavirus disease 2019 patients: A case series.
    Zhang H; Zhu G; Yan L; Lu Y; Fang Q; Shao F
    Artif Organs; 2020 Dec; 44(12):1296-1302. PubMed ID: 32779737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The timing of continuous renal replacement therapy initiation in sepsis-associated acute kidney injury in the intensive care unit: the CRTSAKI Study (Continuous RRT Timing in Sepsis-associated AKI in ICU): study protocol for a multicentre, randomised controlled trial.
    Chen WY; Cai LH; Zhang ZH; Tao LL; Wen YC; Li ZB; Li L; Ling Y; Li JW; Xing R; Liu XY; Lin ZD; Deng ZT; Wang SH; Lin QH; Zhou DR; He ZJ; Xiong XM
    BMJ Open; 2021 Feb; 11(2):e040718. PubMed ID: 33608398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.